Global Neglected Tropical Diseases Diagnosis Market Overview:
Global Neglected Tropical Diseases Diagnosis Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Neglected Tropical Diseases Diagnosis Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Neglected Tropical Diseases Diagnosis involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Neglected Tropical Diseases Diagnosis Market:
The Neglected Tropical Diseases Diagnosis Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Neglected Tropical Diseases Diagnosis Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Neglected Tropical Diseases Diagnosis Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Neglected Tropical Diseases Diagnosis market has been segmented into:
Conventional
Molecular / Modern
By Application, Neglected Tropical Diseases Diagnosis market has been segmented into:
Centralized
Point of Care
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Neglected Tropical Diseases Diagnosis market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Neglected Tropical Diseases Diagnosis market.
Top Key Players Covered in Neglected Tropical Diseases Diagnosis market are:
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories Inc.
Coris Bioconcept SPRL
DiaSys Diagnostic Systems GmbH
F. Hoffmann-La Roche Ltd.
Genome Diagnostics Pvt. Ltd
InBios International Inc.
Life Technology
Novartis Diagnostics. Ltd.
Omega Diagnostics Group PLC
Ortho-Clinical Diagnostics
Oscar Medicare Pvt Ltd.
Premier Medical Corporation Ltd.
Siemens Healthcare
Thermo Fisher Scientific Inc.
Wako Chemicals Inc.
ZeptoMetrix
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Neglected Tropical Diseases Diagnosis Market Type
4.1 Neglected Tropical Diseases Diagnosis Market Snapshot and Growth Engine
4.2 Neglected Tropical Diseases Diagnosis Market Overview
4.3 Conventional
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Conventional: Geographic Segmentation Analysis
4.4 Molecular / Modern
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Molecular / Modern: Geographic Segmentation Analysis
Chapter 5: Neglected Tropical Diseases Diagnosis Market Application
5.1 Neglected Tropical Diseases Diagnosis Market Snapshot and Growth Engine
5.2 Neglected Tropical Diseases Diagnosis Market Overview
5.3 Centralized
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Centralized: Geographic Segmentation Analysis
5.4 Point of Care
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Point of Care: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Neglected Tropical Diseases Diagnosis Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES; BECKMAN COULTER/DANAHER; BIO-RAD LABORATORIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; CORIS BIOCONCEPT SPRL; DIASYS DIAGNOSTIC SYSTEMS GMBH; F. HOFFMANN-LA ROCHE LTD.; GENOME DIAGNOSTICS PVT. LTD; INBIOS INTERNATIONAL
6.4 INC.; LIFE TECHNOLOGY; NOVARTIS DIAGNOSTICS.
6.5 LTD.; OMEGA DIAGNOSTICS GROUP PLC; ORTHO-CLINICAL DIAGNOSTICS; OSCAR MEDICARE PVT LTD.; PREMIER MEDICAL CORPORATION LTD.; SIEMENS HEALTHCARE; THERMO FISHER SCIENTIFIC
6.6 INC.; WAKO CHEMICALS
6.7 INC.; ZEPTOMETRIX
Chapter 7: Global Neglected Tropical Diseases Diagnosis Market By Region
7.1 Overview
7.2. North America Neglected Tropical Diseases Diagnosis Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Conventional
7.2.2.2 Molecular / Modern
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Centralized
7.2.3.2 Point of Care
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Neglected Tropical Diseases Diagnosis Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Conventional
7.3.2.2 Molecular / Modern
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Centralized
7.3.3.2 Point of Care
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Neglected Tropical Diseases Diagnosis Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Conventional
7.4.2.2 Molecular / Modern
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Centralized
7.4.3.2 Point of Care
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Neglected Tropical Diseases Diagnosis Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Conventional
7.5.2.2 Molecular / Modern
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Centralized
7.5.3.2 Point of Care
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Neglected Tropical Diseases Diagnosis Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Conventional
7.6.2.2 Molecular / Modern
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Centralized
7.6.3.2 Point of Care
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Neglected Tropical Diseases Diagnosis Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Conventional
7.7.2.2 Molecular / Modern
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Centralized
7.7.3.2 Point of Care
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Neglected Tropical Diseases Diagnosis Scope:
|
Report Data
|
Neglected Tropical Diseases Diagnosis Market
|
|
Neglected Tropical Diseases Diagnosis Market Size in 2025
|
USD XX million
|
|
Neglected Tropical Diseases Diagnosis CAGR 2025 - 2032
|
XX%
|
|
Neglected Tropical Diseases Diagnosis Base Year
|
2024
|
|
Neglected Tropical Diseases Diagnosis Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories Inc., Coris Bioconcept SPRL, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd., Genome Diagnostics Pvt. Ltd, InBios International Inc., Life Technology, Novartis Diagnostics. Ltd., Omega Diagnostics Group PLC, Ortho-Clinical Diagnostics, Oscar Medicare Pvt Ltd., Premier Medical Corporation Ltd., Siemens Healthcare, Thermo Fisher Scientific Inc., Wako Chemicals Inc., ZeptoMetrix.
|
|
Key Segments
|
By Type
Conventional
Molecular / Modern
By Applications
Centralized
Point of Care
|
